BRIACELL THERAPEUTICS CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BRIACELL THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-04-30 was 76.00K shares, a 9.52% decline year-over-year.
- BRIACELL THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-01-31 was 72.00K shares, a 20.00% increase year-over-year.
- BRIACELL THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-10-31 was 60.00K shares, a 0.00% change year-over-year.
- BRIACELL THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-07-31 was 60.00K shares.
- BRIACELL THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 264.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-04-30 | 76.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-09 | 268.00K shares derived: sum of 4 quarters · filed 2026-06-09 |
| 2026-01-31 | 72.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-10 | 276.00K shares derived: sum of 4 quarters · filed 2026-03-10 |
| 2025-10-31 | 60.00K shares 10-Q · filed 2025-12-11 | 264.00K shares derived: sum of 4 quarters · filed 2025-12-11 |
| 2025-07-31 | 60.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-16 | 264.00K shares 10-K · filed 2025-10-16 |
| 2025-04-30 | 84.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-16 | |
| 2025-01-31 | 60.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-12 | |
| 2024-10-31 | 60.00K shares 10-Q · filed 2024-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |